Graphite Bio is pioneering a precision gene editing approach that has the potential to transform health by achieving one of medicine’s most elusive goals:...
Martin Mendoza, PhD, director of health equity and health science policy for the All of Us Research Program The post The NIH on accelerating research using...
It was only last year that the oral treatment Tembexa was approved by the FDA to treat smallpox, but the drug has already changed hands. Emergent...
In the Phase II VISIONARY-MS trial (NCT03536559), which evaluated CNM-Au8 in participants with stable relapsing remitting multiple sclerosis (RRMS), CNM-Au8...
A submission to the US Food and Drug Administration (FDA) requesting an Emergency Use Authorization (EUA) of a The post Pfizer/BioNTech ask FDA for EUA...
Just 1.5% Of Eligible People Have Gotten Updated COVID Booster Only 1.5% of those eligible to receive the new Covid booster jab - which was...
The FDA is about to lose another top leader with the departure of Sally Choe, director of the FDA’s Office of Generic Drugs, on Oct. 8....
We Might Be Spared Nuclear War For Now But The Threat Of Home-Grown Tyranny Remains Authored by Paul Craig Roberts, As readers know, I am...
Pfizer CEO Has COVID For Second Time In Two Months Pfizer CEO Albert Bourla has tested positive for Covid-19 for the second time in two months....
Cecilia Jones When Cecilia Jones started at Genzyme, there was next to nothing in Kendall Square. “It was just us,” Jones said. “There wasn’t much...
Right around the beginning of the year, we got a close-up look at what happens after a boom ripples through biotech. The crash of life sciences...
One of the features Medtronic touts in its MiniMed 600 series insulin pumps is a series of components that connect wirelessly to allow the remote delivery...
Sesen Bio’s decade-plus journey is over after failing to secure a bladder cancer drug approval and carve its own path for IL-6 antibodies. The Cambridge,...
Sesen Bio’s decade-plus journey is over after failing to secure a bladder cancer drug approval and carve its own path for IL-6 antibodies. The Cambridge,...
In 2018, the leading pharma trade organization PhRMA launched a $10+ million campaign aimed at distancing the industry from then-pharma bro fraudster Martin...
Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of September 12. Aside from presenting a synopsis of events, we provide market...
CytoDyn Inc (OTCMKTS: CYDY) has been on the rise since a brief dip below $0.50 following the recent runup from $0.231 to a high of $1.26...
Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research The post The future of...
Pfizer’s close-fought contest with GSK to bring a next-generation meningitis vaccine to market has entered the final rounds, The post Phase 3 readout...
Let’s pretend, for a minute, that you’re Apple. You didn’t create the smartwatch market, but you currently control more than one-third of it. You’re...
In Alec Baldwin’s famous monologue from “Coffee’s For Closers”, he says – “The… The post Buzz on the Bullboards: The brighter side of a...
Anthony Fauci: From AIDS To COVID-19, A Pharma Love Story Opinion authored by Lorenzo Puertas via The Epoch Times (emphasis ours), After...
Geovax Labs Inc (NASDAQ: GOVX) is a highly volatile stock that spent most of its history on the OTC where we reported on it many times...
FDA Refuses To Provide Key COVID-19 Vaccine Safety Analyses Authored by Zachary Steiber via The Epoch Times (emphasis ours), U.S. drug regulators...
Pfizer and BioNTech’s COVID-19 vaccine targeting Omicron BA.4 and BA.5 has been recommended for authorisation by the EMA’s The post Pfizer’s Omicron...
Now that most people in North America and Europe are vaccinated and the COVID-19 pandemic is diminishing, Moderna is looking for its second act.
Bristol-Myers Squibb’s deucravacitinib– one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – The post BMS scores first...
SAN FRANCISCO, CA—By the time you test positive for COVID-19, the SARS-CoV-2 virus has already taken up residence in your respiratory system. With each...
Adults Aged 35–44 Died At Twice The Expected Rate Last Summer, Life Insurance Data Suggests Authored by Margaret Menge via The Epoch Times...
A team at the University of Michigan has developed a coating for frequently touched surfaces that can rapidly kill a wide array of pathogens, including...